TRIM51

gene
On this page

Also known as TRIM51A

Summary

TRIM51 (tripartite motif-containing 51, HGNC:19023) is a protein-coding gene on chromosome 11q12.1, encoding Tripartite motif-containing protein 51 (Q9BSJ1).

Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response and regulation of gene expression. Predicted to be active in cytoplasm.

Source: NCBI Gene 84767 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 72 total
  • MANE Select transcript: NM_032681

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:19023
Approved symbolTRIM51
Nametripartite motif-containing 51
Location11q12.1
Locus typegene with protein product
StatusApproved
AliasesTRIM51A
Ensembl geneENSG00000124900
Ensembl biotypeprotein_coding
Entrez84767

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000244891, ENST00000449290

RefSeq mRNA: 1 — MANE Select: NM_032681 NM_032681

Canonical transcript exons

ENST00000449290 — 7 exons

ExonStartEnd
ENSE000016675395589113355891810
ENSE000024713995588329755883384
ENSE000024976115588803255888262
ENSE000025062825588897955889001
ENSE000025281925588542555885839
ENSE000025287915588994255890039
ENSE000025289305588612355886218

Expression profiles

Bgee: expression breadth tissue_specific, 3 present calls, max score 82.45.

Top tissues by expression

224 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047382.45gold quality
oocyteCL:000002363.00gold quality
endothelial cellCL:000011561.28gold quality
secondary oocyteCL:000065560.13gold quality
Brodmann (1909) area 46UBERON:000648355.02gold quality
buccal mucosa cellCL:000233653.20gold quality
spermCL:000001952.50gold quality
middle temporal gyrusUBERON:000277151.92gold quality
lower lobe of lungUBERON:000894951.61silver quality
vastus lateralisUBERON:000137951.33gold quality
quadriceps femorisUBERON:000137751.08gold quality
deltoidUBERON:000147646.68gold quality
tendon of biceps brachiiUBERON:000818845.50gold quality
upper leg skinUBERON:000426244.77silver quality
saphenous veinUBERON:000731844.74gold quality
biceps brachiiUBERON:000150743.58gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451143.37gold quality
gingival epitheliumUBERON:000194942.52gold quality
epithelium of nasopharynxUBERON:000195142.01gold quality
superficial temporal arteryUBERON:000161441.33gold quality
entorhinal cortexUBERON:000272841.28gold quality
gingivaUBERON:000182841.23gold quality
oviduct epitheliumUBERON:000480441.16gold quality
palpebral conjunctivaUBERON:000181241.10gold quality
mucosa of paranasal sinusUBERON:000503040.98gold quality
parotid glandUBERON:000183140.86gold quality
medulla oblongataUBERON:000189640.78gold quality
medial globus pallidusUBERON:000247740.77gold quality
amniotic fluidUBERON:000017340.69gold quality
jejunal mucosaUBERON:000039940.59gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes2.77

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

15 targeting TRIM51, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3617-5P99.7569.411968
HSA-MIR-64199.7569.351975
HSA-MIR-33A-3P99.7070.273362
HSA-MIR-4677-5P99.7070.091940
HSA-MIR-6715B-5P99.6469.631420
HSA-MIR-7156-5P99.6468.811369
HSA-MIR-1252-3P99.5567.712862
HSA-MIR-426999.5569.891373
HSA-MIR-472199.2666.05818
HSA-MIR-6739-3P99.2268.841843
HSA-MIR-6506-5P99.0465.661386
HSA-MIR-7151-3P99.0469.722370
HSA-MIR-619-5P98.5764.971988
HSA-MIR-197-3P98.0969.231004
HSA-MIR-431497.5067.301369

Cross-species orthologs

0 orthologs

Paralogs (80): MID2 (ENSG00000080561), TRIM9 (ENSG00000100505), MID1 (ENSG00000101871), MEFV (ENSG00000103313), TRIM35 (ENSG00000104228), TRIM14 (ENSG00000106785), TRIM37 (ENSG00000108395), TRIM2 (ENSG00000109654), TRIM3 (ENSG00000110171), TRIM38 (ENSG00000112343), TRIM62 (ENSG00000116525), TRIM67 (ENSG00000119283), TRIM32 (ENSG00000119401), BSPRY (ENSG00000119411), TRIM25 (ENSG00000121060), TRIM6 (ENSG00000121236), TRIM24 (ENSG00000122779), TRIM28 (ENSG00000130726), TRIM21 (ENSG00000132109), TRIM5 (ENSG00000132256), TRIM22 (ENSG00000132274), TRIM47 (ENSG00000132481), TRIM45 (ENSG00000134253), TRIM29 (ENSG00000137699), TRIM54 (ENSG00000138100), PML (ENSG00000140464), TRIM65 (ENSG00000141569), TRIM43B (ENSG00000144010), TRIM43 (ENSG00000144015), TRIM7 (ENSG00000146054), TRIM41 (ENSG00000146063), TRIM50 (ENSG00000146755), TRIM4 (ENSG00000146833), TRIM55 (ENSG00000147573), TRIM48 (ENSG00000150244), TRIM36 (ENSG00000152503), TRIM11 (ENSG00000154370), TRIM74 (ENSG00000155428), TRIM42 (ENSG00000155890), TRIM63 (ENSG00000158022)

Protein

Protein identifiers

Tripartite motif-containing protein 51Q9BSJ1 (reviewed: Q9BSJ1)

Alternative names: SPRY domain-containing protein 5

All UniProt accessions (1): Q9BSJ1

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the TRIM/RBCC family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9BSJ1-11yes
Q9BSJ1-22

RefSeq proteins (1): NP_116070* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000315Znf_B-boxDomain
IPR001841Znf_RINGDomain
IPR001870B30.2/SPRYDomain
IPR003877SPRY_domDomain
IPR003879Butyrophylin_SPRYDomain
IPR013083Znf_RING/FYVE/PHDHomologous_superfamily
IPR013320ConA-like_dom_sfHomologous_superfamily
IPR017907Znf_RING_CSConserved_site
IPR043136B30.2/SPRY_sfHomologous_superfamily
IPR050143TRIM/RBCCFamily

Pfam: PF00622, PF15227

UniProt features (9 total): binding site 4, zinc finger region 2, chain 1, domain 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BSJ1-F186.800.64

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (4): 93; 96; 115; 121

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 15 (showing top): GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, SOX10_TARGET_GENES, MIR1252_3P, MIR6739_3P, MIR619_5P, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP, GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS, GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP, chr11q12, GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP, GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_DN, JIANG_CORE_DUPLICON_GENES

GO Biological Process (2): regulation of gene expression (GO:0010468), innate immune response (GO:0045087)

GO Molecular Function (4): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
gene expression1
regulation of macromolecule biosynthetic process1
immune response1
defense response to symbiont1
transition metal ion binding1
ubiquitin-protein transferase activity1
ubiquitin-like protein ligase activity1
binding1
cation binding1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

432 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TRIM51SLC45A3Q96JT2588
TRIM51TRIM56Q9BRZ2478
TRIM51PRAMEF13Q5VWM6477
TRIM51OR8J3Q8NGG0476
TRIM51PRAMEF1O95521474
TRIM51PRAMEF11O60813474
TRIM51MS4A2Q01362471
TRIM51GATA2P23769467
TRIM51TRIM52Q96A61459
TRIM51TRIM54Q9BYV2453
TRIM51MS4A1P08984451
TRIM51KHDC1LQ5JSQ8448
TRIM51OR5F1O95221447
TRIM51OR5D16Q8NGK9446
TRIM51OR4A15Q8NGL6445

IntAct

5 interactions, top by confidence:

ABTypeScore
TRIM51psi-mi:“MI:0915”(physical association)0.370
SPRY2TRIM51psi-mi:“MI:0915”(physical association)0.370
RNF40TRIM51psi-mi:“MI:0915”(physical association)0.370
MAGEA11TRIM51psi-mi:“MI:0915”(physical association)0.370

BioGRID (6): TRIM51 (Two-hybrid), TRIM51 (Two-hybrid), TRIM51 (Two-hybrid), TRIM51 (Two-hybrid), TRIM51 (Two-hybrid), TRIM51 (Affinity Capture-MS)

ESM2 similar proteins: A0A3B3IT33, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NLI5, C9J1S8, I1YAP6, K7N6K2, P0CI25, P0CI26, P15533, Q0PF16, Q1ACD5, Q1ACD6, Q1ACD7, Q1ACD8, Q2YEM8, Q2YEM9, Q2YEN0, Q2YEN2, Q3ZEE5, Q587N6, Q587N7, Q5BN31, Q5C8T6, Q5C8T8, Q5C8U1, Q5C8U3, Q5C8U4, Q5D7H7, Q5D7H8, Q5D7I0, Q5D7I1, Q5D7I2, Q5D7I3, Q5D7I5, Q5D7I6, Q5D7I9, Q5D7J0

Diamond homologs: A0A3B3IT33, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NLI5, B0BLU1, C9J1S8, I1YAP6, O00478, O00481, O15344, O75677, O75678, O75679, O76064, P0CI25, P0CI26, P18892, P19474, P62603, P86448, P86449, Q13410, Q2HJ46, Q3C1V9, Q3TL54, Q4KLN8, Q5EBN2, Q5PQN2, Q5R4I2, Q5R996, Q61510, Q62556, Q6INS5, Q6MFY8, Q6UX41, Q6UXE8, Q6ZWI9, Q7T308

SIGNOR signaling

1 interactions.

AEffectBMechanism
Ub:E2“up-regulates activity”TRIM51ubiquitination

Disease & clinical

Clinical variants and AI predictions

ClinVar

72 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance69
Likely benign0
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

617 predictions. Top by Δscore:

VariantEffectΔscore
11:55888025:A:AGacceptor_gain1.0000
11:55888029:CAG:Cacceptor_loss1.0000
11:55888030:A:AGacceptor_gain1.0000
11:55888030:AGGAT:Aacceptor_loss1.0000
11:55888031:G:GTacceptor_gain1.0000
11:55888031:GGA:Gacceptor_gain1.0000
11:55888031:GGAT:Gacceptor_gain1.0000
11:55888031:GGATT:Gacceptor_gain1.0000
11:55888208:A:Tdonor_gain1.0000
11:55888259:CCAG:Cdonor_loss1.0000
11:55888260:CAGG:Cdonor_loss1.0000
11:55888261:AGG:Adonor_loss1.0000
11:55888262:GGTAT:Gdonor_loss1.0000
11:55888263:GTATG:Gdonor_loss1.0000
11:55889937:TGCA:Tacceptor_loss1.0000
11:55889938:GCA:Gacceptor_loss1.0000
11:55889939:CAGGT:Cacceptor_loss1.0000
11:55889940:A:ACacceptor_loss1.0000
11:55889940:A:AGacceptor_gain1.0000
11:55889940:AG:Aacceptor_gain1.0000
11:55889941:G:GCacceptor_gain1.0000
11:55889941:G:Tacceptor_loss1.0000
11:55889941:GG:Gacceptor_gain1.0000
11:55889941:GGT:Gacceptor_gain1.0000
11:55889941:GGTA:Gacceptor_gain1.0000
11:55889941:GGTAT:Gacceptor_gain1.0000
11:55890037:GAG:Gdonor_gain1.0000
11:55890037:GAGGT:Gdonor_loss1.0000
11:55890038:AG:Adonor_gain1.0000
11:55890038:AGG:Adonor_loss1.0000

AlphaMissense

3036 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
11:55891537:T:CF422L0.951
11:55891539:T:AF422L0.951
11:55891539:T:GF422L0.951
11:55885735:T:CF103L0.929
11:55885737:C:AF103L0.929
11:55885737:C:GF103L0.929
11:55891507:T:CF412L0.923
11:55891509:C:AF412L0.923
11:55891509:C:GF412L0.923
11:55890033:T:CF285L0.906
11:55890035:C:AF285L0.906
11:55890035:C:GF285L0.906
11:55891405:T:CF378L0.903
11:55891407:T:AF378L0.903
11:55891407:T:GF378L0.903
11:55885528:T:CF34L0.901
11:55885530:T:AF34L0.901
11:55885530:T:GF34L0.901
11:55891279:T:CF336L0.893
11:55891281:C:AF336L0.893
11:55891281:C:GF336L0.893
11:55886213:T:AW168R0.892
11:55886213:T:CW168R0.892
11:55891330:T:AW353R0.890
11:55891330:T:CW353R0.890
11:55891300:T:AW343R0.888
11:55891300:T:CW343R0.888
11:55891447:T:CF392L0.888
11:55891449:T:AF392L0.888
11:55891449:T:GF392L0.888

dbSNP variants (sampled 300 via entrez): RS1000275832 (11:55883237 AGAG>A), RS1000644677 (11:55882247 A>C), RS1000710829 (11:55883368 A>T), RS1001004660 (11:55887366 A>G), RS1001015383 (11:55882004 T>C), RS1001099089 (11:55887077 G>A), RS1001233696 (11:55892035 GTC>G), RS1001674651 (11:55889575 C>A), RS1001771010 (11:55889346 A>G), RS1002100038 (11:55888243 C>G,T), RS1002683892 (11:55890667 A>G), RS1003127121 (11:55885321 A>G), RS1004066743 (11:55885817 A>C,G), RS1004616734 (11:55884095 C>T), RS1005145652 (11:55886352 AC>A)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST003225_8Pelvic organ prolapse (moderate/severe)5.000000e-06
GCST006916_3Attention deficit hyperactivity disorder4.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases expression, decreases methylation2
Acetaminophendecreases expression1
Arsenicaffects methylation1
Cadmiumdecreases expression1
Rifampindecreases expression1
Aflatoxin B1decreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): pelvic organ prolapse